Register
Forgot your password?

Prospective randomized controlled trial evaluating the efficacy of cryoballoon and radiofrequency pulmonary vein isolation in patients with different forms of atrial fibrillation

Authors: Avanesyan G.A., Shalov R.Z., Filatov A.G., Golukhova E.Z.

Company: Bakoulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russian Federation

For correspondence:  Sign in or register.

Type:  Original articles


DOI: https://doi.org/10.24022/1997-3187-2026-20-1-67-79

For citation: Avanesyan G.A., Shalov R.Z., Filatov A.G., Golukhova E.Z. Prospective randomized controlled trial evaluating the efficacy of cryoballoon and radiofrequency pulmonary vein isolation in patients with different forms of atrial fibrillation. Creative Cardiology. 2026; 20 (1): 67–79 (in Russ.). DOI: 10.24022/1997-3187-2026-20-1-67-79

Received / Accepted:  15.01.2026 / 24.02.2026

Keywords: radiofrequency ablation cryoablation atrial fibrillation



Subscribe 🔒

 

Abstract

Objective: compare the effectiveness of cryoballoon and radiofrequency pulmonary vein isolation in patients with different forms of atrial fibrillation (AF), as well as to identify factors predisposing to arrhythmia recurrence.

Material and methods. In 2023–2024, a single-center prospective study was conducted involving 120 patients with AF who underwent pulmonary vein isolation using either cryoballoon (CBA) or radiofrequency (RFA) ablation. The mean follow-up period was 18.4±1.8 months. Patients were divided into two groups: those with AF recurrence (n=29) and those without recurrence (n=91). The analysis included the impact of comorbidities (diabetes mellitus (DM), arterial hypertension (AH), chronic heart failure (CHF)) and structural changes of the left atrium assessed by echocardiography (EchoCG) and multidetector computed tomography (MDCT) of the left atrium and pulmonary veins on the risk of AF recurrence. Recurrence-free survival was evaluated using the Kaplan–Meier method, and recurrence risk was assessed using Cox regression. The prognostic significance of quantitative parameters was evaluated using ROC analysis.

Results. Patients with recurrence had a higher body mass (p=0.049), a higher prevalence of long-standing persistent AF (27.6% vs 0%, p<0.001), and more frequent comorbidities: DM (48.3% vs 13.2%, p<0.001), AH (79.3% vs 57.1%, p=0.032), and CHF (69.0% vs 26.4%, p<0.001). Left atrial volume by EchoCG (51 mL vs 47 mL, p=0.034) and indexed left atrial volume by MDCT (69.5 mL/m2 vs 62.4 mL/m2, p=0.015) were also higher in patients with recurrence. Survival analysis showed that freedom from recurrence was 80.5% after navigated RFA and 65.7% after CBA (p=0.032). In patients without DM, recurrence-free survival reached 86.5%, whereas the presence of diabetes reduced this value to 50.0% (p=0.001). In the absence of CHF, freedom from recurrence was 86.3%, while in patients with CHF it decreased to 55.7% (p=0.001).

Conclusion. Radiofrequency ablation provides a higher rate of freedom from AF recurrence compared with cryoballoon ablation; however, the choice of ablation technique should be individualized.

References

  1. Hindricks G., Potpara T., Dagres N. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2021; 42 (5): 373–498. DOI: 10.1093/eurheartj/ehaa612
  2. Zoni-Berisso M., Lercari F., Carazza T., Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin. Epidemiol. 2014; 6: 213–220. DOI: 10.2147/CLEP.S47385
  3. Chen Q., Yi Z., Cheng J. Atrial fibrillation in aging population. Aging Med. 2018; 1 (1): 67–74. DOI: 10.1002/agm2.12015
  4. Kuck K.H., Brugada J., Fürnkranz A. et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N. Engl. J. Med. 2016; 374 (23): 2235–2245. DOI: 10.1056/NEJMoa1602014
  5. Stepanova N.M., Serguladze S.Yu., Sopov O.V. et al. Interventional treatment of atrial fibrillation in an elderly patient with severe left atrial fibrosis. Creative Cardiology. 2022; 16 (4): 533–540 (in Russ.). DOI: 10.24022/1997-3187-2022-16-4-533-540
  6. Romanchuk D.V., Khotsanyan Ch.V., Arakelyan M.G. Risk factors for recurrence of atrial fibrillation after catheter ablation. Creative Cardiology. 2023; 17 (1): 50–64 (in Russ.). DOI: 10.24022/1997-3187-2023-17-1-50-64
  7. Kuck K.H., Brugada J., Fürnkranz A. et al.; FIRE AND ICE Investigators. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N. Engl. J. Med. 2016; 374 (23): 2235–2245. DOI: 10.1056/NEJMoa1602014
  8. Andrade J.G., Wells G.A., Deyell M.W. et al. Cryoablation or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: the CIRCA-DOSE study. Circulation. 2019; 140 (22): 1779–1788. DOI: 10.1161/CIRCULATIONAHA.119.042622
  9. Jiang Y., Zhang C., Guo Z. et al. Meta-analysis of cryoballoon vs radiofrequency ablation for atrial fibrillation. J. Cardiol. 2017; 69 (5): 763–770. DOI: 10.1016/j.jjcc.2017.02.012
  10. Basieva M.A., Kazanova P.V., Shvartz V.A. Role of chronic inflammation in the development of recurrent atrial fibrillation after interventional treatment. Annaly Aritmologii. 2024; 21 (1): 39–48 (in Russ.). DOI: 10.15275/annaritmol.2024.1.5
  11. Avanesyan G.A., Filatov A.G., Shalov R.Z. Anatomical and functional remodeling of the left atrium in patients with paroxysmal and persistent atrial fibrillation after cryoballoon pulmonary vein isolation. Creative Cardiology. 2024; 18 (1): 59–72 (in Russ.). DOI: 10.24022/1997-3187-2024-18-1-59-72
  12. Bockeria L.A., Golukhova E.Z., Popov S.V. et al. Clinical guidelines for the diagnosis and treatment of atrial fibrillation and atrial flutter in adults. Ministry of Health of the Russian Federation. Moscow; 2021 (in Russ.).
  13. Wyse D.G., Waldo A.L., DiMarco J.P. et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med. 2002; 347 (23): 1825–1833. DOI: 10.1056/NEJMoa021328
  14. Fuster V., Rydén L.E., Cannom D.S. et al. Management of atrial fibrillation: a report of the American College of Cardiology. Circulation. 2006; 114 (7): e257–e354. DOI: 10.1161/CIRCULATIONAHA.106.177292
  15. Tsao H.M., Wu M.H., Tai C.T. et al. Morphologic remodeling of left atrial-pulmonary veins in atrial fibrillation. J. Cardiovasc. Electrophysiol. 2001; 12 (1): 128–134. DOI: 10.1046/j.1540-8167.2001.00128.x
  16. Tuan T.C., Chang S.L., Tsao H.M. et al. Pulmonary vein anatomy and predictors of atrial fibrillation ablation outcome. Circ. Arrhythm. Electrophysiol. 2010; 3 (3): 381–388. DOI: 10.1161/CIRCEP.109.912519
  17. Park Y.M., Lee J.Y., Kim T.S. et al. Predictors of recurrence after catheter ablation of atrial fibrillation. Int. J. Cardiol. 2013; 166 (2): 311–316. DOI: 10.1016/j.ijcard.2011.10.118
  18. Gupta A., Perera T., Ganesan A. et al. Complications of catheter ablation of atrial fibrillation. Circ. Arrhythm. Electrophysiol. 2015; 6 (5): 1082–1088. DOI: 10.1161/CIRCEP.113.000768
  19. Wu J., Xu J., Cheng L. et al. A systematic review of factors associated with recurrence of atrial fibrillation. J. Cardiol. 2020; 75 (3): 209–216. DOI: 10.1016/j.jjcc.2019.10.007
  20. Andrade J.G., Champagne J., Dubuc M. et al. Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring. J. Am. Coll. Cardiol. 2019; 74 (9): 1217–1227. DOI: 10.1016/j.jacc.2019.06.059
  21. Calkins H., Hindricks G., Cappato R. et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018; 20 (1): e1–e160. DOI: 10.1093/europace/eux274
  22. Keren M.A., Sigaev I.Yu., Osipova A.I. et al. Impact of chronic kidney disease on type of coronary artery bypass grafting and on the structure of postoperative complications in patients with coronary artery disease. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2023; 65 (4): 414–423 (in Russ.). DOI: 10.24022/0236-2791-2023-65-4-414-423
  23. Shalov R.Z., Filatov A.G., Avanesyan G.A. A prospective randomized controlled study evaluating the effectiveness of cryoballoon pulmonary vein isolation in patients with various forms of atrial fibrillation and comorbidities. Part 1. Annaly Aritmologii. 2024; 21 (3): 157–165 (in Russ.). DOI: 10.15275/annaritmol.2024.3.3

About Authors

  • Grayr A. Avanesyan, Cand. Med. Sci., Researcher; ORCID
  • Ruslan Z. Shalov, Cand. Med. Sci., Junior Researcher; ORCID
  • Andrey G. Filatov, Dr. Med. Sci., Head of Department; ORCID
  • Elena Z. Golukhova, Dr. Med. Sci., Professor, Academician of the Russian Academy of Sciences, Director; ORCID

Chief Editor

Elena Z. Golukhova, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, Director of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by